…dscape of ER+ BC. By converting ‘cold’ tumours into ‘hot’ ones, VacV000 holds promise for synergistic use with other immunotherapies.Ac…
Nivolumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Nivolumab
161 articles · page 14 of 14…r exceeding (>50X higher) pharmacodynamic responses reported to vidutolimod, yet with minimal inflammatory cytokine secretion. RNA-seq show…
…with NSCLC on ICI monotherapy with nivolumab, pembrolizumab, or atezolizumab, to identify germline variants associated with objective respon…
…point inhibitor induced liver injury (ChILI) post nivolumab and ipilimumab for metastatic melanoma. Despite treatment with immunosuppressi…
… treatment in five articles and salvage therapy in 10 articles. Nivolumab and ipilimumab were preferred as treatment in 23 patients over …